Tessa Cigler
Cornell University(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer, Hypoxia, and Metabolism, Cancer Treatment and Pharmacology, PARP inhibition in cancer therapy, HER2/EGFR in Cancer Research
Most-Cited Works
- → Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases(2016)219 cited
- → EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer(2015)185 cited
- → Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer(2017)177 cited
- → Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1 - or BRCA2 -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083(2017)96 cited
- → Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse(2013)95 cited
- → Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer(2021)92 cited
- → Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia(2019)74 cited
- → Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency(2020)72 cited
- → Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families(2005)70 cited
- → A new paradigm for mechanobiological mechanisms in tumor metastasis(2012)70 cited